Streetbeat News

Analyst Ratings

AMAT

Morgan Stanley analyst Joseph Moore has maintained an Equal-Weight rating on Applied Materials (NASDAQ:AMAT) and increased the price target from $139 to $142.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 12:58 pm

PALI

Maxim Group analyst Naz Rahman has upgraded Palisade Bio (NASDAQ:PALI) from Hold to Buy and set a price target of $1.5 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 12:58 pm

WRK

Argus Research analyst David Coleman has upgraded WestRock (NYSE:WRK) from Hold to Buy, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 12:45 pm

A

ADI

CMAX

CYBN

EXPE

GLOB

GPS

HUBB

NSSC

WSM

Several top Wall Street analysts have updated their price targets and ratings for various companies. Telsey Advisory Group raised Williams-Sonoma's target and maintained an Outperform rating. Piper Sandler increased Globant's target and kept an Overweight rating. Morgan Stanley upgraded Analog Devices and raised its target. UBS downgraded Agilent Technologies and CareMax, cutting their targets. Telsey Advisory Group lifted The Gap's target and maintained a Market Perform rating. JP Morgan upgraded Hubbell and increased its target. HC Wainwright & Co. lowered Cybin's target but maintained a Buy rating. Needham raised Napco Security Technologies' target and maintained a Buy rating. Evercore ISI Group upgraded Expedia Group and boosted its target.

Portfolio Pulse from Lisa Levin

November 17, 2023 | 12:34 pm

HUBB

JP Morgan analyst Stephen Tusa upgraded Hubbell (NYSE:HUBB) from Neutral to Overweight and increased the price target from $333 to $335.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 12:31 pm

EXPE

Evercore ISI Group analyst Mark Mahaney has upgraded Expedia Group (NASDAQ:EXPE) from In-Line to Outperform and increased the price target from $135 to $200.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 12:24 pm

ZM

Citigroup analyst Tyler Radke has upgraded Zoom Video Communications (ZM) from Sell to Neutral and set a price target of $66.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 12:22 pm

PACB

UBS analyst John Sourbeer has upgraded Pacific Biosciences (NASDAQ:PACB) from Neutral to Buy, while also lowering the price target from $13 to $10.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 12:19 pm

BKD

RBC Capital analyst Ben Hendrix upgraded Brookdale Senior Living (NYSE:BKD) from Sector Perform to Outperform and increased the price target from $7 to $9.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 12:17 pm

ADMA

HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a Buy rating on ADMA Biologics (NASDAQ:ADMA) and maintained a price target of $5.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 12:14 pm